The largest database of trusted experimental protocols

Factor xiiia

Manufactured by Cell Marque

Factor XIIIa is a laboratory reagent used in diagnostic testing. It is a critical component in the blood coagulation cascade, playing a key role in the stabilization of fibrin clots. This product is designed for use in in-vitro diagnostic procedures.

Automatically generated - may contain errors

2 protocols using factor xiiia

1

Immunohistochemical Profiling of Rare Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed on all cases, either at the time of original diagnosis or for the purposes this study. Whole-slide sections of formalin-fixed, paraffin embedded tumor tissue were cut at five-micron thickness, deparaffinized, and subjected to antigen retrieval using 10 mM citrate buffer at 92°C for 30 minutes. Immunohistochemistry was performed on all cases using antibodies for S100 (Ventana Medical Systems, Tucson, AZ), either Smooth Muscle Actin (Ventana) or Calponin (Dako, Carpinteria, CA), SOX10 (BioCare Medical, Concord, CA), Desmin (Dako), and β-catenin (BD Biosciences, San Jose, CA). In addition, for a subset of cases (n=6), PAX3 (Bioss Inc., Wolburn, MA) immunohistochemistry was also performed. Depending on tissue availability, immunohistochemistry was also performed in most cases using antibodies for myogenin (Ventana) and Factor XIIIa (Cell Marque, Rocklin, CA). All immunohistochemical signals were visualized using the Ultra view polymer detection kit (Ventana Medical Systems, Inc. Tucson, AZ) on a Ventana BenchmarkXT autostainer (Ventana). Staining was performed according to manufacturer's instructions in the presence of appropriate controls. “Focal” immunoreactivity was regarded as immunostaining in <10% of tumor cells.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Skin Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
The excision specimen from the left foot comprising skin and subcutaneous tissue was received in buffered neutral formalin. The tumor in the specimen was extensively sampled and processed for routine hematoxylin and eosin–stained sections. Five-μm sections from formalin-fixed, paraffin-embedded tissues were stained with antibodies against CD31 (Neomarker), CD34 (DAKO), ERG (Cell Marque), STAT6 (Cell Marque), Factor XIIIa (Cell Marque), CD163 (Cell Marque), desmin (DAKO), and SMA (DAKO) using the Ventana Optiview detection kit on the Roche Ventana BenchMark ULTRA slide stainer (Roche Diagnostics) after antigen retrieval, if required. For CD34, STAT6, Factor XIIIa, CD163, and desmin stains, the ULTRA cell conditioning method on the Roche Ventana BenchMark ULTRA slide stainer was used for antigen retrieval. For ERG and CD31 stains, the pressure cooker with citrate buffer at pH6 method was employed. For SMA, no antigen retrieval treatment was required.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!